Simplex Trading’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $424K | Buy |
118,500
+62,700
| +112% | +$249K | ﹤0.01% | 3461 |
|
|
2025
Q4 | $196K | Sell |
55,800
-188,000
| -77% | -$644K | ﹤0.01% | 4254 |
|
|
2025
Q3 | $794K | Buy |
243,800
+99,800
| +69% | +$314K | ﹤0.01% | 3286 |
|
|
2025
Q2 | $352K | Buy |
144,000
+58,600
| +69% | +$297K | ﹤0.01% | 3887 |
|
|
2025
Q1 | $569K | Buy |
85,400
+80,500
| +1,643% | +$795K | ﹤0.01% | 3258 |
|
|
2024
Q4 | $61K | Sell |
4,900
-1,900
| -28% | -$28.6K | ﹤0.01% | 5669 |
|
|
2024
Q3 | $125K | Buy |
6,800
+5,700
| +518% | +$117K | ﹤0.01% | 5009 |
|
|
2024
Q2 | $23K | Sell |
1,100
-23,200
| -95% | -$533K | ﹤0.01% | 6780 |
|
|
2024
Q1 | $654K | Sell |
24,300
-24,400
| -50% | -$693K | ﹤0.01% | 3572 |
|
|
2023
Q4 | $1.46M | Buy |
48,700
+20,100
| +70% | +$444K | ﹤0.01% | 2641 |
|
|
2023
Q3 | $586K | Sell |
28,600
-400
| -1% | -$7.27K | ﹤0.01% | 3234 |
|
|
2023
Q2 | $576K | Buy |
29,000
+22,400
| +339% | +$453K | ﹤0.01% | 3154 |
|
|
2023
Q1 | $113K | Sell |
6,600
-64,900
| -91% | -$1.27M | ﹤0.01% | 5017 |
|
|
2022
Q4 | $1.4M | Buy |
71,500
+33,400
| +88% | +$615K | ﹤0.01% | 2153 |
|
|
2022
Q3 | $608K | Buy |
38,100
+31,600
| +486% | +$493K | ﹤0.01% | 3243 |
|
|
2022
Q2 | $89K | Buy |
6,500
+2,800
| +76% | +$33.4K | ﹤0.01% | 5726 |
|
|
2022
Q1 | $58K | Buy |
3,700
+400
| +12% | +$6.91K | ﹤0.01% | 6940 |
|
|
2021
Q4 | $72K | Sell |
3,300
-27,600
| -89% | -$753K | ﹤0.01% | 6740 |
|
|
2021
Q3 | $1.43M | Buy |
30,900
+100
| +0.3% | +$3.64K | ﹤0.01% | 2599 |
|
|
2021
Q2 | $1.36M | Buy |
30,800
+30,633
| +18,343% | +$1.33M | ﹤0.01% | 2687 |
|
|
2021
Q1 | $740K | Buy |
167
+136
| +439% | +$7.47K | ﹤0.01% | 2810 |
|
|
2020
Q4 | $170K | Buy |
+31
| New | +$1.13K | ﹤0.01% | 4827 |
|
|
2020
Q3 | – | Sell |
-6
| Closed | -$12K | – | 8369 |
|
|
2020
Q2 | $12K | Sell |
6
-19
| -76% | -$343 | ﹤0.01% | 6554 |
|
|
2020
Q1 | $34K | Buy |
25
+1
| +4% | +$20 | ﹤0.01% | 5522 |
|
|
2019
Q4 | $54K | Buy |
24
+13
| +118% | +$217 | ﹤0.01% | 5117 |
|
|
2019
Q3 | $12K | Buy |
11
+10
| +1,000% | +$124 | ﹤0.01% | 6153 |
|
|
2019
Q2 | $1K | Sell |
1
-19
| -95% | -$332 | ﹤0.01% | 6902 |
|
|
2019
Q1 | $35K | Buy |
+20
| New | +$316 | ﹤0.01% | 5291 |
|
|
2018
Q2 | – | Sell |
-64
| Closed | -$16K | – | 7797 |
|
|
2018
Q1 | $16K | Buy |
64
+48
| +300% | +$783 | ﹤0.01% | 3576 |
|
|
2017
Q4 | $4K | Sell |
16
-1
| -6% | -$10 | ﹤0.01% | 4729 |
|
|
2017
Q3 | $3K | Sell |
17
-38
| -69% | -$174 | ﹤0.01% | 4840 |
|
|
2017
Q2 | $3K | Buy |
55
+27
| +96% | +$201 | ﹤0.01% | 5013 |
|
|
2017
Q1 | $1K | Buy |
28
+16
| +133% | +$108 | ﹤0.01% | 5756 |
|
|
2016
Q4 | $12K | Sell |
12
-1
| -8% | -$29 | ﹤0.01% | 3575 |
|
|
2016
Q3 | $2K | Buy |
13
+10
| +333% | +$315 | ﹤0.01% | 5023 |
|
|
2016
Q2 | $1K | Buy |
+3
| New | +$105 | ﹤0.01% | 5415 |
|
|
2016
Q1 | – | Sell |
-14
| Closed | -$3K | – | 6118 |
|
|
2015
Q4 | $3K | Buy |
+14
| New | +$610 | ﹤0.01% | 4284 |
|
Other funds holding RCKT
RI
VPM
VCM
MC
NM
N
Simplex Trading's RCKT Position: Q1 2026 in Review
Simplex Trading sold out of Rocket Pharmaceuticals (RCKT) in Q1 2026, closing a stake of 42,495 shares — an estimated $169K sold.
Simplex Trading first reported a position in RCKT in Q2 2016 and held it in 22 quarters. The position peaked at $2.09M in Q3 2023. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.
- Simplex Trading reported no remaining Rocket Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 42,495 Rocket Pharmaceuticals shares in Q1 2026, an estimated $169K.
- Simplex Trading first reported a position in Rocket Pharmaceuticals in Q2 2016 and held it in 22 quarters.
- Simplex Trading's Rocket Pharmaceuticals position peaked at $2.09M in Q3 2023.
- 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.